For me every line of research keeps pointing to Neuren being worth AU$15B-AU$25B ($100 to $200 a share).I see it as the board and managements job to realise this value for shareholders.And everything Neuren are doing (eg preliminary work on another 'less than 10' new disorders) suggests they are indeed working towards that goal.
Like all of us I'm frustrated with where the current share price is and impatient to see Neuren reach $50. But I also felt this too when we were at $1 a share.
However, our patience did end up being rewarded. And I suspect it will again.
For me every line of research keeps pointing to Neuren being...
-
- There are more pages in this discussion • 1,098 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.81 |
Change
0.200(1.47%) |
Mkt cap ! $1.739B | |||
| Open | High | Low | Value | Volume |
| $13.60 | $13.82 | $13.51 | $427.9K | 31.34K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 456 | $13.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.81 | 835 | 9 |
View Market Depth
| Last trade - 10.45am 13/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |